This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Thomas Vincent
Senior Director of Antibody Technology at Alloy Therapeutics


Tom Vincent is Senior Director of Antibody Technology at Alloy Therapeutics. With over 20 years of drug discovery experience, he is a core member of the antibody discovery team, where he co-developed the SeqImmune™ workflow. Prior to his work at Alloy, he focused on therapeutic antibody discovery and engineering at Abeome Corp. Previously, Tom also worked at Ionis Pharmaceuticals and Regulus Therapeutics, where he was a key contributor to multiple successful preclinical and clinical programs in RNA-based therapeutics.

Agenda Sessions

  • Tackling Tough Targets in Antibody Discovery by Leveraging a Diverse Suite of In Vivo Discovery Platforms